TITLE

Expedited transfer for primary percutaneous coronary intervention: a program evaluation

AUTHOR(S)
de Villiers, Jacobus S.; Anderson, Todd; McMeekin, James D.; Leung, Raymond C. M.; Traboulsi, Mouhieddin
PUB. DATE
June 2007
SOURCE
CMAJ: Canadian Medical Association Journal;6/19/2007, Vol. 176 Issue 13, p1833
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: A shorter time from symptom onset to reperfusion is associated with improved outcomes for patients with ST-segment elevation myocardial infarction (MI). Primary percutaneous coronary intervention is a favourable method of reperfusion if performed effectively and expeditiously. We sought to evaluate the impact of an expedited pre-hospital diagnosis and transfer pathway developed by a multidisciplinary team on the door-to-balloon time in a large urban community. Methods: We included all patients with ST-segment elevation MI who presented within 12 hours after symptom onset and who sought medical attention through Emergency Medical Services within the boundaries of the city of Calgary in the 16 months following the introduction of the pathway in June 2004. The primary aim was to determine the proportion of patients who received percutaneous coronary intervention within the recommended door-to-balloon time of 90 minutes. Results: The 358 patients (268 men) in the study cohort had a mean age of 63.2 (standard deviation 12.7) years; 140 (39.1%) had an anterior MI; and 23 (6.4%) had cardiogenic shock. The introduction of the pathway resulted in a median door-to-balloon time of 62 (interquartile range 45-84) minutes. A door-to-balloon time within 60 minutes and within the currently recommended 90 minutes was achieved in 48.9% and 78.8% of the patients respectively. The in-hospital and 30-day mortality rates were both 3.1%. Interpretation: In a community with multiple regional hospitals and a single facility for percutaneous coronary intervention, the implementation of a multidisciplinary prehospital diagnosis and transfer pathway was feasible and resulted in most patients in the study cohort receiving primary percutaneous coronary intervention within the recommended door-to-balloon time of 90 minutes.
ACCESSION #
25360417

 

Related Articles

  • Reduced between-hospital variation in short term survival after acute myocardial infarction: the result of improved cardiac care? Murphy, N. F.; Maclntyre, K.; Stewart, S.; Capewell, S.; McMurray, J. J. V. // Heart;Jun2005, Vol. 91 Issue 6, p726 

    Objectives: To re-examine interhospital variation in 30 day survival after acute myocardial infarction (AMI) 10 years on to see whether the appointment of new cardiologists and their involvement in emergency care has improved outcome after AMI. Design: Retrospective cohort study. Setting: Acute...

  • …and how many angioplasties?  // Cortlandt Forum;Jan2007, Vol. 20 Issue 1, p14 

    The article reports on a research on medical practices in using angioplasty after three days to patients with heart failure. This procedure is not efficient and could even cause harm. The study concluded that percutaneous coronary intervention did not reduce the occurrence and risk of this...

  • Nine-year comparison of presentation and management of acute coronary syndromes in Ireland: a national cross-sectional survey. Doyle, Frank; De La Harpe, Davida; McGee, Hannah; Shelley, Emer; Conroy, Ronán // BMC Cardiovascular Disorders;2005, Vol. 5, p5 

    Background: Shorter time to treatment is associated with lower mortality in acute coronary syndromes (ACS). A previous (1994) survey showed substantial delays for acute myocardial infarction (AMI) in Ireland. The present study compared current practice with 1994 and surveyed acute coronary...

  • The role of nurses in improving emergency cardiac care.  // Nursing Standard;8/10/2005, Vol. 19 Issue 48, p41 

    Cardiovascular diseases exert a huge burden on individuals and society, with coronary heart disease (CHD) the single most common cause of death in the United Kingdom and other developed countries (British Heart Foundation 2004). Improved clinical care has been responsible for around two fifths...

  • Intravenous Esmolol is Well Tolerated in Elderly Patients with Heart Failure in the Early Phase of Non-ST Elevation Myocardial Infarction. Koutouzis, Michael; Nikolidakis, Savvas; Grigoriadis, Anestis; Koutsogeorgis, Dimitrios; Kyriakides, Zenon S. // Drugs & Aging;2006, Vol. 23 Issue 8, p673 

    AIM: To investigate the haemodynamic response to and clinical safety and tolerability of intravenous esmolol (Brevibloc, Baxter Healthcare Corporation, Deerfield, Illinois, USA) in elderly and younger patients with acute non-ST elevation myocardial infarction (NSTEMI) and heart failure. ...

  • Equal access to treatment? Population-based follow-up of drugs dispensed to patients after acute myocardial infarction in Sweden. Ringbäck Weitoft, G.; Ericsson, Ö.; Löfroth, E.; Rosén, M. // European Journal of Clinical Pharmacology;Apr2008, Vol. 64 Issue 4, p417 

    The establishment of national guidelines is one approach to creating equity in terms of access to care, and both internationally and in Sweden, guidelines have been developed for coronary heart disease. We have analysed drug treatment in Sweden according to national guidelines after acute...

  • Dental prophylaxis decreases the risk of acute myocardial infarction: a nationwide population-based study in Taiwan. Ya-Ling Lee; Hsiao-Yun Hu; Pesus Chou; Dachen Chu // Clinical Interventions in Aging;2015, Vol. 10, p175 

    Purpose: To investigate the association between periodontal disease (PD) and acute myocardial infarction (AMI), and evaluate the effect of dental prophylaxis on the incidence rate (IR) of AMI. Methods: The Longitudinal Health Insurance Database 2000 from the National Health Insurance program was...

  • Angiotensin Inhibition After Myocardial Infarction: Does Drug Class Matter? Winkelmayer, Wolfgang C.; Fischer, Michael A.; Schneeweiss, Sebastian; Levin, Raisa // JGIM: Journal of General Internal Medicine;Dec2006, Vol. 21 Issue 12, p1242 

    BACKGROUND: Angiotensin converting enzyme-inhibitors (ACEI) and angiotensin-II-receptor blockers (ARB) are equally efficacious in reducing mortality after MI, although the latter are far more costly. Little is known about their relative use after MI in typical care settings, and about their...

  • Trusts phasing out singlehanders.  // Pulse;12/12/2007, Vol. 67 Issue 45, p4 

    The article reports that primary care trusts (PCTs) are implementing policies aimed to reduce numbers of singlehanded practices, due to poor performance in Quality and Outcomes Framework (QOF) as evaluated by the Healthcare Commission in Great Britain. It reveals that practices had depicted...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics